• LAST PRICE
    0.0361
  • TODAY'S CHANGE (%)
    Trending Down-0.0139 (-27.8000%)
  • Bid / Lots
    0.0021/ 100
  • Ask / Lots
    0.2000/ 25
  • Open / Previous Close
    0.1500 / 0.0500
  • Day Range
    Low 0.0361
    High 0.1500
  • 52 Week Range
    Low 0.0210
    High 0.1500
  • Volume
    2,000
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.0361
TimeVolumeAGTX
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAGTX
Agentix Corp
2.0M
-6.1x
---
United StatesSLRX
Salarius Pharmaceuticals Inc
2.0M
-0.2x
---
United StatesENTO
Entero Therapeutics Inc
1.9M
-0.1x
---
United StatesBJDX
Bluejay Diagnostics Inc
1.9M
0.0x
---
United StatesBTAX
Biostax Corp
1.9M
-1.2x
---
United StatesDRMA
Dermata Therapeutics Inc
1.8M
-0.1x
---
As of 2024-11-22

Company Information

Agentix Corp. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic agents for the treatment of metabolic diseases like Type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Its pipeline includes AGTX-2004 and AGTX-2003. AGTX-2004 is a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus (T2DM). AGTX-2003 is a peripherally-acting CB1 receptor inverse agonist that has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver disease. The Company is focused on the development of synthetic agonists, inverse agonists, and antagonists, which modulate the endocannabinoid system (ECS). The ECS is the regulatory system which governs metabolism. The Company’s wholly owned subsidiaries include GSL Healthcare, Inc., Agentix Australia Pty Ltd, and Applied Biopharma LLC.

Contact Information

Headquarters
32932 PACIFIC COAST HIGHWAY, #14-254DANA POINT, CA, United States 92629
Phone
321-229-2014
Fax
---

Executives

Treasurer, Company Secretary, Director
Salman Hoda
Director
Riazul Huda

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4M
Revenue (TTM)
$0.00
Shares Outstanding
40.1M
Agentix Corp does not pay a dividend.
Beta
-0.32
EPS
$-0.01
Book Value
$-0.06
P/E Ratio
-6.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.